Pacific Hospital Supply (4126) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 太醫

Pacific Hospital Supply (4126) reported revenue of NT$203.6 million for Oct 2026, -6.3% year on year and -7.3% from the previous month. Revenue for Jan–Oct 2026 was NT$2.06 billion (+0.4% year on year).

In Oct 2026, it ranked No. 39 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$198.1 million24/10Nov 2024 NT$222.9 millionDec 2024 NT$218.4 millionJan 2025 NT$172.6 millionFeb 2025 NT$177.4 million25/02Mar 2025 NT$254.5 millionApr 2025 NT$173.8 millionMay 2025 NT$216.5 millionJun 2025 NT$175.5 million25/06Jul 2025 NT$223.6 millionAug 2025 NT$222.3 millionSep 2025 NT$213.3 millionOct 2025 NT$217.4 million25/10Nov 2025 NT$165.6 millionDec 2025 NT$193.5 millionJan 2026 NT$200.2 millionFeb 2026 NT$145.5 million26/02Mar 2026 NT$236 millionApr 2026 NT$183.4 millionMay 2026 NT$212.2 millionJun 2026 NT$207.4 million26/06Jul 2026 NT$224.7 millionAug 2026 NT$223.1 millionSep 2026 NT$219.6 millionOct 2026 NT$203.6 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$203.6 million-6.3%-7.3%
Sep 2026NT$219.6 million+3.0%-1.5%
Aug 2026NT$223.1 million+0.4%-0.7%
Jul 2026NT$224.7 million+0.5%+8.3%
Jun 2026NT$207.4 million+18.2%-2.3%
May 2026NT$212.2 million-2.0%+15.7%
Apr 2026NT$183.4 million+5.6%-22.3%
Mar 2026NT$236 million-7.3%+62.2%
Feb 2026NT$145.5 million-18.0%-27.3%
Jan 2026NT$200.2 million+16.0%+3.4%
Dec 2025NT$193.5 million-11.4%+16.9%
Nov 2025NT$165.6 million-25.7%-23.8%
Oct 2025NT$217.4 million+9.8%+1.9%
Sep 2025NT$213.3 million+25.7%-4.0%
Aug 2025NT$222.3 million+3.4%-0.6%
Jul 2025NT$223.6 million+15.0%+27.4%
Jun 2025NT$175.5 million-10.6%-18.9%
May 2025NT$216.5 million+13.3%+24.6%
Apr 2025NT$173.8 million-1.0%-31.7%
Mar 2025NT$254.5 million+12.4%+43.4%
Feb 2025NT$177.4 million+24.6%+2.8%
Jan 2025NT$172.6 million-11.6%-21.0%
Dec 2024NT$218.4 million+29.0%-2.0%
Nov 2024NT$222.9 million+28.7%+12.5%
Oct 2024NT$198.1 million+11.7%+16.7%

Jan–Oct 2026 cumulative: NT$2.06 billion (+0.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Pacific Hospital Supply vs PEC / Pacific Hospital Supply vs Lotus Pharm / Pacific Hospital Supply vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16